Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

AURORA CANNABIS Aktie

 >AURORA CANNABIS Aktienkurs 
3.768 EUR    -2.9%    (TradegateBSX)
Ask: 3.82 EUR / 5000 Stück
Bid: 3.766 EUR / 5000 Stück
Tagesumsatz: 4868 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
Aktie über LYNX handeln
>AURORA CANNABIS Performance
1 Woche: -16,7%
1 Monat: +6,9%
3 Monate: +16,4%
6 Monate: +25,3%
1 Jahr: +6,9%
laufendes Jahr: +2,1%
>AURORA CANNABIS Aktie
Name:  AURORA CANNABIS
Land:  Kanada
Sektor:  Gesundheit
ISIN/ Wkn:  CA05156X8504 / A4ZZ0W
Symbol/ Ticker:  21P (Frankfurt) / ACB (NASDAQ)
Kürzel:  FRA:21P, ETR:21P, 21P:GR, NASDAQ:ACB
Index:  -
Profil:  Aurora Cannabis Inc. is a Canadian cannabis company focused on the production, distribution, and sale of cannabis and cannabis-derived products in Canada and international markets. Aurora Cannabis Inc. serves both medical and consumer segments with o..
>Volltext..
Marktkapitalisierung:  250.27 Mio. EUR
Unternehmenswert:  181.11 Mio. EUR
Umsatz:  182.99 Mio. EUR
EBITDA:  -92.97 Mio. EUR
Nettogewinn:  -51.33 Mio. EUR
Gewinn je Aktie:  -0.86 EUR
Schulden:  13.73 Mio. EUR
Liquide Mittel:  73.83 Mio. EUR
Operativer Cashflow:  -1.68 Mio. EUR
Bargeldquote:  1.74
Umsatzwachstum:  -21.13%
Gewinnwachstum:  -37.9%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  AURORA CANNABIS
Letzte Datenerhebung:  21.11.26
>Kennzahlen
Aktien/ Unternehmen:
Aktien: 65.75 Mio. St.
Frei handelbar: 99.38%
Rückkaufquote: -6.7%
Mitarbeiter: 1028
Umsatz/Mitarb.: 0.2 Mio. EUR
Analysten:
Analystenrating: Neutral
Kursziel: 19.89%
Bewertung:
KGV: -
KGV lG: -
KUV: 1.42
KBV: 0.77
PEG-Ratio: -0.15
EV/EBITDA: -
Rentabilität:
Bruttomarge: 14.79%
Gewinnmarge: -2.6%
Operative Marge: -54.17%
Managementeffizenz:
Gesamtkaprendite: -1.08%
Eigenkaprendite: -1.42%
>Peer Group
Gesundheit, Cannabis- Produkte
 
16.11.26 - 22:48
Why Didn′t Tilray Brands Make a Bid for Aurora Cannabis? (Fool)
 
Multiple companies have made offers for Aurora's business this year, but Tilray hasn't shown any interest....
10.11.26 - 13:48
Curaleaf Receives All Required Competition Law Clearances for Proposed Acquisition of Aurora Cannabis (PR Newswire)
 
STAMFORD, Conn., Nov. 10, 2026 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) (the "Company"), a leading international provider of consumer and medical cannabis products, today announced that it has received competition law clearances in Germany and Canada for its......
09.11.26 - 20:01
The Big Winner From the Aurora Cannabis-Organigram Deal: Curaleaf (Fool)
 
Organigram is valuing Aurora Cannabis more highly than Curleaf, but that doesn't mean it's the best option for shareholders in the long run....
05.11.26 - 20:24
Aurora Cannabis Inc. reports Q2 results (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
05.11.26 - 13:09
Aurora Cannabis Announces Fiscal 2027 Second Quarter Results (Business Wire)
 
Delivers Net Revenue of $86.0 Million, Including Record International Medical Cannabis Net Revenue of $61.4 Million, Representing a 44% Yoy Increase Generated Adjusted EBITDA1 of $14.0 Million, With Free Cash Flow1 Outflow Improving by $22.4 Million Maintains Strong Balance Sheet With $133.0 Million of Cash, Cash Equivalents2 and Short-Term Investments With No Debt EDMONTON, Alberta--(BUSINESS WIRE)--Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ | TSX: ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the second quarter 2027 ending September 30, 2026. Aurora has cancelled its investor call, originally scheduled for November 12, 2026, at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time, due to the Company's announcement on November 3, 2026, that Aurora has entered into a definitive agreement (the “Arrangement Agreement”) with Organigram Global Inc. (“Organigram”) pursuant to which Organigram will acquire all o...
04.11.26 - 09:48
Übernahmeangebot von Organigram Global treibt Aurora Cannabis-Aktie um mehr als 22 % nach oben (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
03.11.26 - 23:48
Curaleaf Issues Statement Regarding Alternative Proposal for Aurora Cannabis (PR Newswire)
 
STAMFORD, Conn., Nov. 3, 2026 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf"), a leading international provider of consumer and medical cannabis products, today acknowledges the announcement by Aurora Cannabis Inc. (TSX: ACB) (NASDAQ: ACB) ("Aurora") of an......
03.11.26 - 18:12
Organigram outbids Curaleaf with C$561M deal for Aurora Cannabis (Proactive Investors)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
03.11.26 - 16:09
Organigram to buy Aurora Cannabis amid hostile bid from Curaleaf (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
29.10.26 - 12:06
Aurora Cannabis to Host Second Quarter 2027 Investor Conference Call (Business Wire)
 
EDMONTON, Alberta--(BUSINESS WIRE)--Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today that it will host an investor conference call on Thursday, November 12, 2026 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time to discuss its financial results for the second quarter 2027. The Company will report its financial results prior to market open that same morning. Investor Conference Call Details DATE: Thursday, November 12, 2026 TIME: 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time WEBCAST: Click Here Miguel Martin, Executive Chairman and Chief Executive Officer, and Simona King, Chief Financial Officer, will host the call and question and answer period. This weblink has also been posted to the Company's "Investor Info" link at www.auroramj.com/investors under "Events". As a reminder, shareholders are advised to REJECT Curaleaf's Hostile Bid by TAKING NO ACTION and NOT TENDERING...
27.10.26 - 18:45
ACB′s Q2 Earnings on Deck: International Medical Cannabis in Focus (Zacks)
 
Aurora Cannabis heads into Q2 earnings with revenues expected to fall 20.1%, as market exits and reimbursement cuts weigh on results while international medical cannabis markets offer support....
26.10.26 - 23:33
Curaleaf challenge to Aurora Cannabis at-the-market program fails (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
19.10.26 - 13:21
Curaleaf Challenges Aurora′s Unilateral Rejection of Its Enhanced Proposal (PR Newswire)
 
STAMFORD, Conn., Oct. 19, 2026 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer and medical cannabis products, today responded to Aurora Cannabis Inc.'s ("Aurora") Notice of Change to its......
14.10.26 - 23:06
Aurora Cannabis tells shareholders to reject Curaleaf′s revised bid (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
14.10.26 - 21:54
Aurora Cannabis Reaffirms Recommendation to Shareholders: REJECT Curaleaf′s Revised Hostile Bid; Preserve Opportunities for Future Upside (PR Newswire)
 
NASDAQ | TSX: ACB Revised Hostile Bid continues to significantly undervalue Aurora; fails to address concerns previously raised by the Board. Aurora's Special Committee is actively exploring strategic alternatives to maximize value for Aurora shareholders. Shareholders are advised to......
13.10.26 - 15:36
Cannabissektor in Aufruhr: Drama um Tilray-Zahlen: Anleger zittern nun vor Canopy, Aurora Cannabis & Co. (Wallstreet-Online)
 
Abseits haussierender Ölpreise und wankender Aktienmärkte findet das Siechtum im Cannabis-Sektor seine Fortsetzung. Der Quartalsbericht von Tilray sollte neue Hoffnung bringen – und enttäuschte. ...
12.10.26 - 23:12
Aurora Cannabis Stock Has Soared 25% Since Curaleaf First Made an Offer to Buy Its Business. Here′s Why I Think It Can Go Even Higher (Fool)
 
Curaleaf looks eager to buy Aurora Cannabis, and that's helped to drive its value up....
08.10.26 - 16:12
Tilray Brands Sinks 4% as Record Revenue Masks Shrinking Cannabis Sales; Canopy Growth and Aurora Cannabis Ease (24/7 Wall St.)
 
A Q1 FY2027 revenue record from Tilray Brands (NASDAQ:TLRY) is drawing heavy selling, because the segment that built the company's following moved the wrong way. Tilray Brands shares are at $3.56, down 4% this morning, as the company's cannabis sales contracted while its beer and distribution units carried the top line. Meanwhile, Canopy Growth (NASDAQ:CGC) […]...
05.10.26 - 20:36
Market movers: SpaceX, Nu Holdings, Aurora Cannabis, Great Plains Metals... (Proactive Investors)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
05.10.26 - 14:21
Curaleaf enhances offer to acquire Aurora Cannabis (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Wenn die Augen weinen, bleibt auch die Nase nicht ruhig. - Sprichwort Deutschland
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!